Vicky Tagalakis

Vicky Tagalakis

Auto-generated profile, based on publicly available information

Vicky Tagalakis

Centre for Clinical Epidemiology, Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Québec, Canada

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2013 in The American Journal of Medicine
Verified
Journal Article
Closed access
VTVicky Tagalakis
Vicky Tagalakis
VPValérie Patenaude
Valérie Patenaude
SKSusan R. Kahn
Susan R. Kahn
SSSamy Suissa
Samy Suissa

1 August 2007 in Journal of Thoracic Oncology
Verified
Journal Article
Closed access
VTVicky Tagalakis
Vicky Tagalakis
DLDahlia Levi
Dahlia Levi
JAJason S. Agulnik
Jason S. Agulnik
VCVictor Cohen
Victor Cohen
GKGoulnar Kasymjanova
Goulnar Kasymjanova
DSDavid Small
David Small

24 July 2007 in BMC Cardiovascular Disorders
Verified
Journal Article
Open access
PDF file
TIthe SOX Trial Investigators
the SOX Trial Investigators
SKSusan R Kahn
Susan R Kahn
HSHadia Shbaklo
Hadia Shbaklo
SSStan Shapiro
Stan Shapiro
PWPhilip S Wells
Philip S Wells
VTVicky Tagalakis
Vicky Tagalakis
Post thrombotic syndrome (PTS) is a burdensome and costly complication of deep venous thrombosis (DVT) that develops in 20–40% of patients within 1–2 years after symptomatic DVT. Affected patients have chronic leg pain and swelling and may develop ulcers. Venous valve disruption from the thrombus itself or thrombus-associated mediators of inflammation is considered to be a key initiating event for the development of venous hypertension that often underlies PTS. As existing treatments for PTS are extremely limited, strategies that focus on preventing the development of PTS in patients with DVT are more likely to be effective and cost-effective in reducing its burden. Elastic compression stockings (ECS) could be helpful in preventing PTS; however, data on their effectiveness are scarce and conflicting.

1 May 2007 in The Lancet Oncology
Verified
Journal Article
Closed access
VTVicky Tagalakis
Vicky Tagalakis
HTHani Tamim
Hani Tamim
MBMark Blostein
Mark Blostein
JCJean-Paul Collet
Jean-Paul Collet
JHJames A Hanley
James A Hanley
SKSusan R Kahn
Susan R Kahn

1 May 2016 in The Journal of Pediatrics
Verified
Journal Article
Closed access
CSChristine A. Sabapathy
Christine A. Sabapathy
TDTina N. Djouonang
Tina N. Djouonang
SKSusan R. Kahn
Susan R. Kahn
RPRobert W. Platt
Robert W. Platt
VTVicky Tagalakis
Vicky Tagalakis

1 June 2007 in Cancer Treatment Reviews
Verified
Journal Article
Closed access
VTVicky Tagalakis
Vicky Tagalakis
MBMark Blostein
Mark Blostein
CRCassianne Robinson-Cohen
Cassianne Robinson-Cohen
SKSusan R. Kahn
Susan R. Kahn